Applying CPT and HCPCS C-Codes and Rules for Drug Administration Services to Clinical Scenarios

Similar documents
Infusion Coding Infusions, Pushes, Injections

Outpatient Infusion Coding & Documentation: Take Your Skills to a Higher Level

BILLING & CODING MEDICAL ONCOLOGY. Risë Marie Cleland, Oplinc Inc. June 2017

Billing for Infusion Services in an Outpatient Neurology Clinic. Christine Mann, MBA Director of Infusion Services Dent Neurologic Institute

Type Days HRG Procurement 1 Cost and Volume Delivery 1 Day case. Weekly for 30 weeks. 1-14inc Capecitabine 1250mg/m² twice daily

Coding Tips, Hints & Pointers for Medical Oncology Billing

Infusion Coding. Is this going to hurt? Presented by: Annalynn Hall, M.Ed, CPC, CHONC. Codes

Davis s Drug Guide Scavenger Hunt 15 th Edition

Clinical Policy: Ramucirumab (Cyramza) Reference Number: CP.PHAR.119

Jonathan Dickinson, LCL Xeloda

Medicinae Doctoris. One university. Many futures.

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

Ensuring Accuracy: Chargemaster and Outpatient Facility Coding

Toxicities of Chemotherapy Regimens used in Early Breast Cancer

Cancer SLO Practice (online set) Page 1 of 5

05/01/2014. Medicare has 4 parts A: Hospital coverage National Training Program. Session Objectives. The Basics. B: Outpatient medical coverage

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Etiologies:

GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION

Perioperative chemotherapy: individualized therapy or same treatment for all? Prof. Dr. med. Salah-Eddin Al-Batran

Reporting Mammograms for Medicare Patients Coding these preventive procedures depends on the payer.

Are we making progress? Marked reduction in operative morbidity and mortality

Is There a New Standard of Care for Adjuvant Therapy in Colon Cancer? When is 3 Months Enough?

Van Cutsem E et al. Proc ASCO 2009;Abstract LBA4509.

Re: Comprehensive Ambulatory Payment Classification Methodology

Docetaxel. Class: Antineoplastic agent, Antimicrotubular, Taxane derivative.

The PARADIGM Study: A Phase III Study Comparing Sequential Therapy (ST) to Concurrent Chemoradiotherapy (CRT) in Locally Advanced Head and Neck Cancer

亞東紀念醫院 Breast Cancer 化學治療處方集

ADULT Updated: September 4, 2018

Genomic Health, Inc. Oncotype DX Colon Cancer Assay Clinical Compendium March 30, 2012

Medicare Part C Medical Coverage Policy

CHEMOTHERAPY FOR METASTATIC GASTRIC CANCER

Optimal adjuvant therapy for colon cancer is FOLFOX for 6 cycles YES

NCCN Chemotherapy Order Templates

ONCOLOGY LETTERS 2: , 2011

OVERALL CLINICAL BENEFIT

EVIDENCE IN BRIEF OVERALL CLINICAL BENEFIT

Chemotherapy of Breast Cancer

C ODING PAIN C LINICS. After attending this presentation, attendee will be able to: Coding Check List

NCCP Chemotherapy Regimen. FLOT Therapy-14 day

Trends and Comparative Effectiveness in Treatment of Stage IV Colorectal Adenocarcinoma

Panel Two: Evidence for Use of Maintenance Therapy

See Important Reminder at the end of this policy for important regulatory and legal information.

Lisa M. Hess Diane Michael Daniel S. Mytelka Julie Beyrer Astra M. Liepa Steven Nicol

ANAPLASTIC LARGE CELL LYMPHOMA TREATMENT ROAD MAP (Modified ALCL99)

Oncology Competency Self Assessment

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

See Important Reminder at the end of this policy for important regulatory and legal information.

Subject: Palonosetron Hydrochloride (Aloxi )

Active Cancer Studies by Approval Date For additional information on any one of these studies contact the Lancaster General Cancer Center

Targeted Therapies in Metastatic Colorectal Cancer: An Update

MASCC Guidelines for Antiemetic control: An update

See Important Reminder at the end of this policy for important regulatory and legal information.

Third Line and Beyond: Management of Refractory Colorectal Cancer

Cetuximab with Chemotherapy as Treatment for Stage III Colon or Metastatic Colorectal Cancer

MP Laboratory Testing to Allow Area Under the Curve (AUC) Targeted 5- Flourouracil (5-FU) Dosing for Patients Administered 5-FU for Cancer

1-844-FAX-A360 ( )

Advances in gastric cancer: How to approach localised disease?

Clinical Policy: Cetuximab (Erbitux) Reference Number: PA.CP.PHAR.317

Clinical Policy: Cetuximab (Erbitux) Reference Number: ERX.SPA.261 Effective Date:

To help doctors give their patients the best possible care, the American

Gastroesophag Gastroesopha eal Junction Adenocarcinoma: What is the best adjuvant regimen? Michael G. G. H addock Haddock M.D.

Gemcitabine + Cisplatin Regimen

Pharmacy Management Drug Policy

Symptom Management. Thomas McKain, MD, ABFM, ABHPM Medical Director

Auditors Desk Reference

Advances in Chemotherapy of Colorectal Cancer

International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry. Types I, II and III PPB

Reference No: Author(s) Approval date: 12/05/16. Committee. June Operational Date: Review:

Two Cycles of Chemoradiation: 2 Cycles is Enough. Concurrent Chemotherapy / RT Regimens

EVIDENCE IN BRIEF OVERALL CLINICAL BENEFIT

Conflicts of Interest GI Malignancies: An Update on Current Treatment Options

TESTS AND MONITORING:

Cisplatin + Etoposide + Thoracic Radiotherapy (TRT) INDICATIONS FOR USE:

Injectable Opioid Shortage: February 27, 2018

Resectable locally advanced oesophagogastric cancer

pan-canadian Oncology Drug Review Final Economic Guidance Report Irinotecan liposome (Onivyde) for Metastatic Pancreatic Cancer January 5, 2018

Index. Note: Page numbers of article titles are in boldface type.

Disclosures. Colorectal Cancer Update GAFP November Risk Assessment. Colon and Rectal Cancer The Challenge. Issues in Colon and Rectal Cancer

Chemotherapy of colon cancers

Policy. ( Number: *Pleasesee amendment forpennsylvaniamedicaidatthe endofthis CPB.

Irinotecan. Class:Camptothecin. Indications : _Cervical cancer. _CNS tumor. _Esophageal cancer. _Ewing s sarcoma. _Gastric cancer

Eloxatin (Oxaliplatin)

Ping-Tsung Chen, MD; Chuang-Chi Liaw, MD

Haematology, Oncology and Palliative Care Directorate.

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

Erbitux. Erbitux (cetuximab) Description

Cisplatin and Vinorelbine and radiotherapy (NSCLC)

Pancreatic Cancer Where are we?

Cisplatin and Vinorelbine and radiotherapy (NSCLC)

Symptom Management of Gastrointestinal Alterations

MEDICARE RECOVERY AUDIT CONTRACTORS

Fluorouracil, Oxaliplatin and Docetaxel (FLOT)

Medicare Program: Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs

MEETING SUMMARY ESMO 2018, Munich, Germany. Dr. Jenny Seligmann University of Leeds, UK HIGHLIGHTS ON COLORECTAL CANCER

Front-line treatment in young. Role of maintenance therapy. Rome 2017 Prof Le Gouill S.

Nausea and Vomiting. Symptom Management of Gastrointestinal Alterations. Gastrointestinal Alterations. Nausea/Vomiting Patterns

CBC with Differential. PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

Medical Therapies in Ovarian Cancer The Arabic Perspectives. Mezghani Bassem -Tunisia

Cyramza (ramucirumab)

Transcription:

Applying CPT and HCPCS C-Codes and Rules for Drug Administration Services to Clinical Scenarios

IMPORTANT PLEASE READ The information provided in this handout is informational only and should not be taken as an official answer of how to report codes and units for the services described in these clinical scenarios. Our audioconference speakers have provided this in an attempt to help hospitals sort through a number of drug administration reporting issues, but each hospital must make its own determination of how to report these services to Medicare and non-medicare payers. If you are confused or disagree, we urge you to request guidance from your FI and CMS. We cannot provide any further information or explanations at this time. If you have further questions, please contact Nimitt Consulting at jugna@nimitt.com to engage consulting services.

Answer for Clinical Example 1: Emergency Department Visit for a Gastric Ulcer Patient ED Visit Example 2006 CPT Codes for non- Medicare use 2006 HCPCS C- codes for Medicare Use Service Time Explanation 2006 Codes 2006 Codes IVP 14:00 Protonix 90774 x 1 C8952 x 1 IVP 14:10 Demoral 90775 x 1 C8952 x 1 IVP 14:15 Ativan 90775 x 1 C8952 x 1 ED Visit ED Level III 99283 x 1 99283 x 1 Page 1

Answer for Clinical Example 2: Emergency Department and Observation Visit for a Gastric Ulcer Patient ED and Observation Example 2006 CPT Codes for non- Medicare use 2006 HCPCS C- codes for Medicare Use Service Time Explanation 2006 Codes 2006 Codes IVP 14:00 Protonix 90774 x 1 C8952 x 1 IVP 14:10 Demoral 90775 x 1 C8952 x 1 IVP 14:15 Ativan 90775 x 1 C8952 x 1 ED Visit ED Level III 99283 x 1 99283 x 1 Observation 14:30-16:30 Admit to Obs 99235 x 2 G0378 x 2 Infusion started in Observation 14:30-16:30 Therapeutic Infusion 90767 x 1 90766 x 1 C8950 x 1 C8951 x 1 IVP 16:30 Dilaudid 90775 x 1 C8952 x 1 Page 2

Answer for Clinical Example 3: Multiple Push Injections of the Same Drug Chemo Regimen 2005 Hospital Reporting 2005 CPT 2006 C- Service Time Explanation Codes 2006 CPT Codes Codes IVP 1000-1005 Lasix 90784 x 1 90774 x 1 C8952 x 1* IVP 1110-1115 Lasix 90784 x 1 IVP 1300-1305 Lasix 90784 x 1 IVP 1500-1505 Lasix 90784 x 1 2006 CPT Codes for non- Medicare use 2006 HCPCS C-Codes for Medicare Use

Answer for Clinical Example 4: Concept of Concurrent Drug and CMS Administration as Presented at the CPT Symposium in Chicago 2006 CPT Codes Service Time Explanation for non- Medicare use 2006 C-Codes for Medicare Use IVPB 1000-1100 Antibiotic 1 90765 x 1 C8950 x1 IVPB 1000-1100 Antibiotic 2 90768 x 1 No Medicare C-code available to report concurrent infusion IVP 1115-1125 Phenrgan 90775 x 1 C8952 x 1 This is the answer presented by physicians at the CPT meeting in Chicago. We believe that there is no way to report the second antibiotic infusion on the Medicare side given that there is no code available and also because both infusions are of the same type. If the concurrent infusion was of a different type (i.e., a chemotherapy drug infusion), then we believe guidance from Transmittal 785 would allow us to report Page 4 both the antibiotic and the chemo infusion.

Answer for Clinical Example 5: Two Chemotherapy Push Drugs with a Non-Chemotherapy Drug Two Different Chemo Drugs Given IVP and Non- Chemo by IVP 2006 CPT Codes Non-Medicare Use 2006 CPT and HCPCS C-codes for Medicare Use Service Time Explanation 2006 Codes 2006 codes IVP 9:00 PS-341 (chemo) 96409 x 1 C8953 x 1 IVP 10:02 5FU (chemo) 96411 x 1 C8953 x 1 IVP 9:30 Leucovorin (nonchemo) 90775 x 1 C8952 x 1 Page 5

Answer to Clinical Example 6: Chemotherapy Infusion with Anti-Emetics Chemo Regimen 2006 CPT Codes for Non-Medicare use 2006 HCPCS C-codes for Medicare Use Service Time Explanation 2006 Codes 2006 Codes Decadron/Aloxi (nonchemo) C8952 x 90775 x 1 IVP 10:00-10:10 1 IVP 10:10-10:20 Reglan (non-chemo) 90775 x 1 C8952 x 1 IV infusion 12:20-14:20 Cisplatin (chemo) 96413 x 1 96415 x 1 C8954 x 1 C8955 x 1 Page 6

Answer to Clinical Example 7: Chemotherapy Infusion with Anti-Emetics, Pre-and- Post Hydration, and Additional Meds Chemo Regimen 2006 CPT Codes for non- Medicare use 2006 C-codes for Medicare Use Service Time Explanation 2006 Codes 2006 Codes Decadron/Aloxi (nonchemo) C8952 x 90775 x 1 IVP 10:00-10:10 1 IVP 10:10-10:20 Reglan (non-chemo) 90775 x 1 C8952 x 1 IV infusion 10:20-12:20 Hydration 90761 x 2 C8950 x 1 C8951 x 1 IV infusion 12:20-14:20 Cisplatin (chemo) 96413 x 1 96415 x 1 C8954 x 1 C8955 x 1 IVP 14:20-14:55 Mannitol (non-chemo) 90775 x 1 C8952 x 1 IV infusion 14:55-16:55 Hydration 90761 x 2 C8951 x 2 IV infusion 16:55-17:55 Etoposide (chemo) 96417 x 1 C8955 x 1 IVP 17:55-18:05 Bleomyocin (chemo) 96411 x 1 C8953 x 1 Page 7

Answer to Clinical Example 8: Concept of Sequential Drug Administration as Presented at the CPT Symposium in Chicago Chemo Regimen 2006 CPT Codes for non- Medicare use 2006 HCPCS C- Codes for Medicare Use 2006 CPT Service Time Explanation Codes 2006 C-Codes IVP 9:00-9:20 Ativan (non-chemo) 90775 x 1 C8952 x 1 IVPB 9:25-9:45 Decadron, Zofran, Benadryl (non-chemo) 90767 x 1 C8950 x 1 IV Infusion 9:45-10:45 Paraplatin (chemo) 96413 x 1 C8954 x 1 IV Infusion 10:45-11:15 Cytoxan (chemo) 96417 x 1 N/A Note: There is no sequential chemotherapy infusion C-code available to report to Medicare. Also, the total time of the Paraplatin and Cytoxan does not meet the time requirement to bill any additional hours using the C8955 add-on code. Page 8

Answer for Clinical Example 9: Chemotherapy Infusion and Hydration with Overlapping Time Chemo Regimen w/ hydration hour overlapping with Chemo Infusion 2006 CPT Codes for non-medicare use 2006 HCPCS C-codes for Medicare Use Service Time Explanation 2006 CPT Codes 2006 codes IVP 13:15 (15 min) Zofran (non-chemo) 90775 x 1 C8952 x 1 IV infusion 13:15-16:45 Hydration 90761 x 3 OR see below C8950 x 1 C8951 x 2 or see below Codes/units if overlapping time for Cytoxan and Taxotere is deducted (hydration then = 45 minutes) 90761 x 1 C8950 X 1 IVP 13:25-13:55 Adriamycin (chemo) 96411 x 1 C8953 x 1 IV infusion 14:00-15:30 Cytoxan (chemo) 96413 x 1 C8954 x 1 IV infusion 15:30-16:30 Taxotere (chemo) 96417 x 1 C8955 x 1 Since the hydration runs throughout the course of the chemotherapy infusion, many hospitals are only reporting the non-overlapping hydration time and not the overlapping time (i.e., not the full duration of the hydration if it overlaps). Please request clarification from your FI and/or CMS. Page 9

Answer to Clinical Example # 10: Concept of Concurrent Infusions Under CPT Codes vs. Medicare C-Codes 2006 CPT Codes 2006 HCPCS C- for non-medicare codes for use Medicare Use Service Time Explanation 2006 CPT Codes 2006 Codes SAMPLE FOLFOX REGIMEN Chemotherapy drug infusion 10:00 to 12:00 The drug Oxaliplatin is infused concurrently with the non-chemo Leucovorin drug through "Y" tubing. Oxaliplatin is compatible with Leucovorin, but not the second chemo drug Fluorouracil. Order reads: Oxaliplatin 85mg/m2 IVPB Run in 2 hrs. 96413 x 1 96415 x 1 C8954 x 1 C8955 x 1 Nonchemotherapy drug infusion 10:00 to 12:00 The non-chemo drug Leucovorin is infused concurrently with the chemo drug Oxaliplatin through "Y" tubing. Order reads: Leucovorin 200mg/m2 IVPB run in 2 hrs.mg/m2 IVPB Run in 2 hrs. 90768 x 1 C8950 x 1 C8951 x 1 Chemotherapy drug injection 12:10 Fluorouracil given by the hospital as an IVP 96411 x 1 C8953 x 1 There is no concurrent infusion C-code for Medicare. However, in this example, two different types of services are running concurrently (chemo and non-chemo). We believe Transmittal 785 allows for both of these services to be reported. The concept of concurrent is not well-defined, therefore hospitals should request clarification from their FI and/or CMS to determine how they will report this. We have requested official guidance but have not received a response as of Feb 3, 2006. Page 10